Sign In to Follow Application
View All Documents & Correspondence

Skin Protective Composition, And Implementation Thereof

Abstract: The present disclosure discloses a composition comprising: (a) Morns alba root extract; (b) Moringa oleifera seed extract; and (c) Vitis vinifera seed extract, wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 0.5-2:0.5-2:0.5-2. The composition as disclosed herein provides protection to the skin by inhibiting the production of ROS during exposure to the harmful radiations.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
29 March 2019
Publication Number
40/2020
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
iprdel@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore

Inventors

1. MUTHAIYAH, Balu
ITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
2. VIJAYAN, Santhosh Viren
ITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
3. BANDYOPADHYAY, Balaji
ITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
4. KALSI, Gurpreet
ITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
5. RAMAMURTHI, Suresh
ITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
6. CHANDRASEKHARAN, Lakshmanan Chittur
ITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058

Specification

I/We Claim:
1. A composition comprising:
a) Morus alba root extract;
b) Moringa oleifera seed extract; and
c) Vitis vinifera seed extract,
wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 0.5-2:0.5-2:0.5-2.
2. The composition as claimed in claim 1, wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 1:1:1.
3. The composition as claimed in claim 1, wherein the Morus alba root extract has a weight percentage in a range of 0.005-0.02% with respect to the composition.
4. The composition as claimed in claim 1, wherein the Moringa oleifera seed extract has a weight percentage in a range of 0.005-0.02% with respect to the composition.
5. The composition as claimed in claim 1, wherein the Vitis vinifera seed extract has a weight percentage in a range of 0.005-0.02%) with respect to the composition.
6. The composition as claimed in claim 1, wherein the Morus alba root extract has a weight percentage of 0.01% with respect to the composition, the Moringa oleifera seed extract has a weight percentage of 0.01% with respect to the composition, and the Vitis vinifera seed extract has a weight percentage of 0.01% with respect to the composition.
7. The composition as claimed in claim 1, wherein the Morus alba root extract comprises oxyresveratrol in a weight percentage in a range of 0.5%-2 % with respect to the extract, the Moringa oleifera seed extract comprises saponin in a weight percentage in a range of 0.1%-0.5% with respect to the extract, and the Vitis vinifera seed extract comprises proanthocyanidin in a weight percentage in a range of 0.1%-0.5% with respect to the extract.

8. A process for preparing the composition as claimed in claim 1, said process
comprising:
a) obtaining Morus alba root extract;
b) obtaining Moringa oleifera seed extract;
c) obtaining Vitis vinifera seed extract; and
d) contacting the Morus alba root extract, the Moringa oleifera seed extract, and the Vitis vinifera seed extract, to obtain the composition.
9. The composition as claimed in any one of the claims 1-7, wherein the
composition inhibits production of reactive oxygen species (ROS).

Documents

Application Documents

# Name Date
1 201941012741-STATEMENT OF UNDERTAKING (FORM 3) [29-03-2019(online)].pdf 2019-03-29
2 201941012741-FORM 1 [29-03-2019(online)].pdf 2019-03-29
3 201941012741-DRAWINGS [29-03-2019(online)].pdf 2019-03-29
4 201941012741-DECLARATION OF INVENTORSHIP (FORM 5) [29-03-2019(online)].pdf 2019-03-29
5 201941012741-COMPLETE SPECIFICATION [29-03-2019(online)].pdf 2019-03-29
6 201941012741-Proof of Right (MANDATORY) [25-06-2019(online)].pdf 2019-06-25
7 201941012741-FORM-26 [25-06-2019(online)].pdf 2019-06-25
8 Correspondence by Agent_Form1 And Power of Attorney_27-06-2019.pdf 2019-06-27
9 201941012741-FORM 18 [06-03-2023(online)].pdf 2023-03-06
10 201941012741-FER.pdf 2023-10-12
11 201941012741-OTHERS [11-04-2024(online)].pdf 2024-04-11
12 201941012741-FER_SER_REPLY [11-04-2024(online)].pdf 2024-04-11
13 201941012741-Response to office action [04-07-2024(online)].pdf 2024-07-04
14 201941012741-US(14)-HearingNotice-(HearingDate-29-08-2025).pdf 2025-08-04
15 201941012741-FORM-26 [20-08-2025(online)].pdf 2025-08-20
16 201941012741-Correspondence to notify the Controller [26-08-2025(online)].pdf 2025-08-26
17 201941012741-Written submissions and relevant documents [11-09-2025(online)].pdf 2025-09-11

Search Strategy

1 SearchHistoryE_11-10-2023.pdf
2 201941012741_SearchStrategyAmended_E_Skin_Morus_VitiAE_30-07-2025.pdf